These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 18974575

  • 1. Correlation of urinary monocyte chemo-attractant protein-1 with other parameters of renal injury in type-II diabetes mellitus.
    Ibrahim S, Rashed L.
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):911-7. PubMed ID: 18974575
    [Abstract] [Full Text] [Related]

  • 2. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
    Shaker OG, Sadik NA.
    Hum Exp Toxicol; 2013 Oct; 32(10):1089-96. PubMed ID: 23515495
    [Abstract] [Full Text] [Related]

  • 3. Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy.
    Tam FW, Riser BL, Meeran K, Rambow J, Pusey CD, Frankel AH.
    Cytokine; 2009 Jul; 47(1):37-42. PubMed ID: 19409809
    [Abstract] [Full Text] [Related]

  • 4. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A, Bdeer Sel-A, El-Sokkary RH.
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [Abstract] [Full Text] [Related]

  • 5. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy.
    Morii T, Fujita H, Narita T, Shimotomai T, Fujishima H, Yoshioka N, Imai H, Kakei M, Ito S.
    J Diabetes Complications; 2003 Oct; 17(1):11-5. PubMed ID: 12505750
    [Abstract] [Full Text] [Related]

  • 6. Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases.
    Morii T, Fujita H, Narita T, Koshimura J, Shimotomai T, Fujishima H, Yoshioka N, Imai H, Kakei M, Ito S.
    Ren Fail; 2003 May; 25(3):439-44. PubMed ID: 12803507
    [Abstract] [Full Text] [Related]

  • 7. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.
    Banba N, Nakamura T, Matsumura M, Kuroda H, Hattori Y, Kasai K.
    Kidney Int; 2000 Aug; 58(2):684-90. PubMed ID: 10916091
    [Abstract] [Full Text] [Related]

  • 8. Nuclear NF-κB p65 in peripheral blood mononuclear cells correlates with urinary MCP-1, RANTES and the severity of type 2 diabetic nephropathy.
    Yi B, Hu X, Zhang H, Huang J, Liu J, Hu J, Li W, Huang L.
    PLoS One; 2014 Aug; 9(6):e99633. PubMed ID: 24936866
    [Abstract] [Full Text] [Related]

  • 9. Intensive insulin therapy decreases urinary MCP-1 and ICAM-1 excretions in incipient diabetic nephropathy.
    Ye SD, Zheng M, Zhao LL, Qian Y, Yao XM, Ren A, Li SM, Jing CY.
    Eur J Clin Invest; 2009 Nov; 39(11):980-5. PubMed ID: 19663918
    [Abstract] [Full Text] [Related]

  • 10. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy.
    Fujita H, Morii T, Koshimura J, Ishikawa M, Kato M, Miura T, Sasaki H, Narita T, Ito S, Kakei M.
    Endocr J; 2006 Dec; 53(6):745-52. PubMed ID: 16966829
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
    Wang QY, Chen FQ.
    Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
    [Abstract] [Full Text] [Related]

  • 12. Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
    Fufaa GD, Weil EJ, Nelson RG, Hanson RL, Knowler WC, Rovin BH, Wu H, Klein JB, Mifflin TE, Feldman HI, Vasan RS, Kimmel PL, Kusek JW, Mauer M, CKD Biomarkers Consortium and the RASS Investigators.
    Nephrol Dial Transplant; 2015 Apr; 30(4):599-606. PubMed ID: 25648911
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus.
    Bouvet BR, Paparella CV, Arriaga SM, Monje AL, Amarilla AM, Almará AM.
    Arq Bras Endocrinol Metabol; 2014 Nov; 58(8):798-801. PubMed ID: 25465599
    [Abstract] [Full Text] [Related]

  • 14. [Urinary excretion of proinflammatory cytokines and transforming growth factor beta at early stages of diabetic nephropathy].
    Bondar' IA, Klimontov VV, Nadeev AP.
    Ter Arkh; 2008 Nov; 80(1):52-6. PubMed ID: 18326229
    [Abstract] [Full Text] [Related]

  • 15. Association of urinary monocyte chemoattractant protein-1 (MCP-1) and kidney injury molecule-1 (KIM-1) with risk factors of diabetic kidney disease in type 2 diabetes patients.
    Siddiqui K, Joy SS, Al-Rubeaan K.
    Int Urol Nephrol; 2019 Aug; 51(8):1379-1386. PubMed ID: 31250339
    [Abstract] [Full Text] [Related]

  • 16. Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy.
    Tashiro K, Koyanagi I, Saitoh A, Shimizu A, Shike T, Ishiguro C, Koizumi M, Funabiki K, Horikoshi S, Shirato I, Tomino Y.
    J Clin Lab Anal; 2002 Aug; 16(1):1-4. PubMed ID: 11835523
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the urinary kidney injury molecule-1 levels in patients with diabetic nephropathy.
    Kin Tekce B, Tekce H, Aktas G, Sit M.
    Clin Invest Med; 2014 Dec 01; 37(6):E377-83. PubMed ID: 25618270
    [Abstract] [Full Text] [Related]

  • 18. Estimation of transforming growth factor-beta 1 as a marker of renal injury in type II diabetes mellitus.
    Ibrahim S, Rashed L.
    Saudi Med J; 2007 Apr 01; 28(4):519-23. PubMed ID: 17457470
    [Abstract] [Full Text] [Related]

  • 19. Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease.
    Camilla R, Brachemi S, Pichette V, Cartier P, Laforest-Renald A, MacRae T, Madore F, Troyanov S.
    J Nephrol; 2011 Apr 01; 24(1):60-7. PubMed ID: 20437404
    [Abstract] [Full Text] [Related]

  • 20. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
    Guo KF, Kou JX, Lu JX, Zhang L, Yu HY, Chen HB.
    Zhonghua Yi Xue Za Zhi; 2013 Apr 09; 93(14):1067-71. PubMed ID: 23902838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.